Protectus Medical Device
Generated 5/10/2026
Executive Summary
Protectus Medical Devices, Inc. is a San Diego-based medical device company founded in 2012, focused on preventing needlestick injuries among healthcare workers through its patented automatic self-sheathing safety syringes. The lead product, Protectus Safety Syringe, has received FDA 510(k) clearance and is positioned to address a significant occupational hazard in healthcare settings. With over 600,000 needlestick injuries annually in the U.S., the demand for effective safety-engineered devices is strong, driven by regulatory mandates and hospital safety protocols. Protectus's proprietary design automatically sheaths the needle after use, reducing the risk of accidental sticks without requiring additional steps from the user. The company targets the global safety syringe market, projected to exceed $10 billion by 2030, and is poised to capture share through its differentiated technology and regulatory approvals. While still private with limited public information, Protectus represents a compelling opportunity in the medical safety device space, supported by a clear regulatory pathway and growing awareness of occupational hazards.
Upcoming Catalysts (preview)
- Q4 2026Commercial scale-up or first major hospital system contract70% success
- H1 2027Additional FDA clearance for next-generation syringe or variant60% success
- Q2 2027Strategic partnership or licensing deal with a larger medtech distributor55% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)